Chlamydophila pneumoniae infection and cardiovascular disease
Authors:
Open Access
- 1 January 2013
- journal article
- review article
- Published by Medknow in North American Journal of Medical Sciences
- Vol. 5 (3) , 169-81
Abstract
Atherosclerosis is a multifactorial vascular inflammatory process; however, the inciting cause for inflammation remains unclear. Two decades ago, Chlamydophila pneumoniae (formerly Chlamydia pneumoniae) infection was proposed as a putative etiologic agent. We performed a PubMed search using the keywords Chlamydia and atherosclerosis in a Boolean query to identify published studies on C. pneumoniae and its role in atherogenesis, and to understand research interest in this topic. We found 1,652 published articles on this topic between 1991 and 2011. We analyzed relevant published studies and found various serological, molecular, and animal modeling studies in the early period. Encouraged by positive results from these studies, more than a dozen antibiotic clinical-trials were subsequently conducted, which did not find clinical benefits of anti-Chlamydophila drug therapy. While many researchers believe that the organism is still important, negative clinical trials had a similar impact on overall research interest. With many novel mechanisms identified for atherogenesis, there is a need for newer paradigms in Chlamydophila-atherosclerosis research.Keywords
This publication has 97 references indexed in Scilit:
- Association of Carotid Plaque Lp-PLA2 with Macrophages and Chlamydia pneumoniae Infection among Patients at Risk for StrokePLOS ONE, 2010
- Essential Role of Mitochondrial Antiviral Signaling, IFN Regulatory Factor (IRF)3, and IRF7 in Chlamydophila pneumoniae -Mediated IFN-β Response and Control of Bacterial Replication in Human Endothelial CellsThe Journal of Immunology, 2010
- Elevated levels of anti-Chlamydia pneumoniae IgA and IgG antibodies in young adults with ischemic strokeActa Neurologica Scandinavica, 2007
- Increased Aortic Intima-Media Thickness in 11-Year-Old Healthy Children With Persistent Chlamydia pneumoniae SeropositivityArteriosclerosis, Thrombosis, and Vascular Biology, 2006
- Presence of Chlamydia pneumoniae in patients with and without atherosclerosisEuropean Journal of Clinical Microbiology & Infectious Diseases, 2005
- Prevalence of viable Chlamydia pneumoniae in peripheral blood mononuclear cells of healthy blood donorsTransfusion, 2004
- Heart disease: the greatest `risk' factor of them allMedical Hypotheses, 2004
- Joint effects of Chlamydia pneumoniae infection and classic coronary risk factors on risk of acute myocardial infarctionAmerican Heart Journal, 2003
- Effect of short-term treatment with azithromycin on recurrent ischaemic events in patients with acute coronary syndrome in the Azithromycin in Acute Coronary Syndrome (AZACS) trial: a randomised controlled trialThe Lancet, 2003
- Meta-analysis of sero-epidemiologic studies of the relation between Chlamydia pneumoniae and atherosclerosis: Does study design influence results?American Heart Journal, 2003